A major step forward in treating inherited blood disorders in Qatar Sidra Medicine a member of Qatar Foundation is now ...
Using CRISPR, multiomics, and machine learning, molecular biologist Larschan unravels the mysteries of the X chromosome.
Qatar Tribune on MSN
Sidra Medicine introduces gene-editing therapy for sickle cell disease and thalassaemia
Tribune News NetworkDohaSidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a limited number of hospitals in the world to administer Casgevy, a ...
Qatar has taken a landmark step in precision medicine after Sidra Medicine became the first hospital in the country — and one ...
Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of ...
Challenges include high costs and limited diagnosis, but opportunities for growth lie in gene therapy commercialization, expanded screening, and emerging marketsDublin, April 21, 2026 (GLOBE NEWSWIRE) ...
Tanzania is scaling up the fight against malaria by introducing advanced gene-modification technology targeting mosquitoes ...
For the first time, a team of researchers from Stellenbosch University (SU) and the Agricultural Research Council has ...
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results